{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:44:17Z","timestamp":1789080257424,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001500"],"award-info":[{"award-number":["82001500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04378-3","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:08:35Z","timestamp":1759918115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated VAMP8 expression promotes cervical cancer progression by enhancing autophagy via HIF-1 pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijuan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"3","key":"4378_CR1","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20(3):2058\u201374.","journal-title":"Oncol Lett"},{"key":"4378_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gore.2017.08.004","volume":"22","author":"AW LaVigne","year":"2017","unstructured":"LaVigne AW, Triedman SA, Randall TC, Trimble EL, Viswanathan AN. Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery. Gynecol Oncol Rep. 2017;22:16\u201320.","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"4378_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","volume":"32","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720\u20138.","journal-title":"Chin J Cancer Res"},{"key":"4378_CR4","doi-asserted-by":"publisher","unstructured":"Choi S, Ismail A, Pappas-Gogos G, Boussios S. HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens (Basel, Switzerland). 2023;12(2). https:\/\/doi.org\/10.3390\/pathogens12020298.","DOI":"10.3390\/pathogens12020298"},{"issue":"5","key":"4378_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602\u20138.","journal-title":"J Obstet Gynaecol"},{"key":"4378_CR6","doi-asserted-by":"publisher","unstructured":"Yeo-Teh NSL, Ito Y, Jha S. High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. Int J Mol Sci. 2018;19(6). https:\/\/doi.org\/10.3390\/ijms19061706.","DOI":"10.3390\/ijms19061706"},{"key":"4378_CR7","doi-asserted-by":"publisher","unstructured":"Porter VL, Marra MA. The drivers, mechanisms, and consequences of genome instability in HPV-driven cancers. Cancers (Basel). 2022;14(19). https:\/\/doi.org\/10.3390\/cancers14194623.","DOI":"10.3390\/cancers14194623"},{"issue":"2","key":"4378_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5455\/msm.2020.32.127-130","volume":"32","author":"M Jahic","year":"2020","unstructured":"Jahic M, Kameric L, Hadzimehmedovic A. Progression low squamous intraepithelial lesion and human papillomavirus infections. Mater Socio-Med. 2020;32(2):127\u201330.","journal-title":"Mater Socio-Med"},{"key":"4378_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.25259\/Cytojournal_24_2021","volume":"18","author":"A Alrajjal","year":"2021","unstructured":"Alrajjal A, Pansare V, Choudhury MSR, Khan MYA, Shidham VB. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of uterine cervix and Bethesda system. Cytojournal. 2021;18:16.","journal-title":"Cytojournal"},{"key":"4378_CR10","doi-asserted-by":"publisher","unstructured":"Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, et al. Molecular markers to predict prognosis and treatment response in uterine cervical cancer. Cancers (Basel). 2021;13(22). https:\/\/doi.org\/10.3390\/cancers13225748.","DOI":"10.3390\/cancers13225748"},{"key":"4378_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1277772","volume":"13","author":"A Jafari","year":"2023","unstructured":"Jafari A, Farahani M, Abdollahpour-Alitappeh M, Manzari-Tavakoli A, Yazdani M, Rezaei-Tavirani M. Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells. Front Oncol. 2023;13:1277772.","journal-title":"Front Oncol"},{"key":"4378_CR12","doi-asserted-by":"publisher","unstructured":"Ouh YT, Kim HY, Yi KW, Lee NW, Kim HJ, Min KJ. Enhancing cervical cancer screening: review of p16\/Ki-67 dual staining as a promising triage strategy. Diagnostics (Basel, Switzerland). 2024;14(4). https:\/\/doi.org\/10.3390\/diagnostics14040451.","DOI":"10.3390\/diagnostics14040451"},{"issue":"2","key":"4378_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/0974-2727.199630","volume":"9","author":"A Hebbar","year":"2017","unstructured":"Hebbar A, Murthy VS. Role of p16\/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: an institutional study. J Lab Physicians. 2017;9(2):104\u201310.","journal-title":"J Lab Physicians"},{"issue":"15","key":"4378_CR14","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","volume":"18","author":"N Wentzensen","year":"2012","unstructured":"Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, et al. Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18(15):4154\u201362.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"4378_CR15","first-page":"Ec17","volume":"11","author":"V Kishore","year":"2017","unstructured":"Kishore V, Patil AG. Expression of p16INK4A protein in cervical intraepithelial neoplasia and invasive carcinoma of uterine cervix. Journal of clinical and diagnostic research\u202f: JCDR. 2017;11(9):Ec17-ec20.","journal-title":"Journal of clinical and diagnostic research : JCDR"},{"issue":"12","key":"4378_CR16","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.7150\/jca.32743","volume":"10","author":"L Yu","year":"2019","unstructured":"Yu L, Fei L, Liu X, Pi X, Wang L, Chen S. Application of p16\/Ki-67 dual-staining cytology in cervical cancers. J Cancer. 2019;10(12):2654\u201360.","journal-title":"J Cancer"},{"issue":"8","key":"4378_CR17","first-page":"Cd008587","volume":"8","author":"G Koliopoulos","year":"2017","unstructured":"Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(8):Cd008587.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"4378_CR18","doi-asserted-by":"publisher","first-page":"e1915781","DOI":"10.1001\/jamanetworkopen.2019.15781","volume":"2","author":"L Torres-Ibarra","year":"2019","unstructured":"Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, et al. Comparison of HPV-16 and HPV-18 genotyping and cytological testing as triage testing within human papillomavirus-based screening in Mexico. JAMA Netw Open. 2019;2(11):e1915781.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"4378_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234518","volume":"15","author":"F Song","year":"2020","unstructured":"Song F, Du H, Wang C, Huang X, Wu R. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples. PLoS ONE. 2020;15(6):e0234518.","journal-title":"PLoS ONE"},{"key":"4378_CR20","doi-asserted-by":"crossref","unstructured":"Kumar GV, Prabhu AJ, Sebastian A, Raghavendran, Abraham P, Peedicayil A.\u00a0P16INK4a\/ki67 Immunocytochemistry in Improving the Predictive Value for High Grade Cervical Intraepithelial\u00a0(\u2265CIN2) Neoplasia in Pap Smear. J Cytol. 2021;38(4):180-5.","DOI":"10.4103\/JOC.JOC_245_20"},{"issue":"8","key":"4378_CR21","first-page":"4109","volume":"11","author":"X Zhang","year":"2018","unstructured":"Zhang X, Shen D. p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion. Int J Clin Exp Pathol. 2018;11(8):4109\u201316.","journal-title":"Int J Clin Exp Pathol"},{"issue":"48","key":"4378_CR22","doi-asserted-by":"publisher","first-page":"83890","DOI":"10.18632\/oncotarget.19870","volume":"8","author":"HR Wang","year":"2017","unstructured":"Wang HR, Li YC, Guo HQ, Yu LL, Wu Z, Yin J, et al. A cocktail of p16(INK4a) and Ki-67, p16(INK4a) and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening. Oncotarget. 2017;8(48):83890\u20139.","journal-title":"Oncotarget"},{"issue":"40","key":"4378_CR23","doi-asserted-by":"publisher","first-page":"28040","DOI":"10.1074\/jbc.M114.593913","volume":"289","author":"SW Messenger","year":"2014","unstructured":"Messenger SW, Falkowski MA, Thomas DD, Jones EK, Hong W, Gaisano HY, et al. Vesicle associated membrane protein 8 (VAMP8)-mediated zymogen granule exocytosis is dependent on endosomal trafficking via the constitutive-like secretory pathway. J Biol Chem. 2014;289(40):28040\u201353.","journal-title":"J Biol Chem"},{"issue":"34","key":"4378_CR24","doi-asserted-by":"publisher","first-page":"29627","DOI":"10.1074\/jbc.M111.265199","volume":"286","author":"N Behrendorff","year":"2011","unstructured":"Behrendorff N, Dolai S, Hong W, Gaisano HY, Thorn P. Vesicle-associated membrane protein 8 (VAMP8) is a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) selectively required for sequential granule-to-granule fusion. J Biol Chem. 2011;286(34):29627\u201334.","journal-title":"J Biol Chem"},{"issue":"10","key":"4378_CR25","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1080\/15548627.2020.1823124","volume":"17","author":"X Tian","year":"2021","unstructured":"Tian X, Teng J, Chen J. New insights regarding SNARE proteins in autophagosome-lysosome fusion. Autophagy. 2021;17(10):2680\u20138.","journal-title":"Autophagy"},{"issue":"1","key":"4378_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/MCB.00814-09","volume":"30","author":"CC Wang","year":"2010","unstructured":"Wang CC, Ng CP, Shi H, Liew HC, Guo K, Zeng Q, et al. A role for VAMP8\/endobrevin in surface deployment of the water channel aquaporin 2. Mol Cell Biol. 2010;30(1):333\u201343.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4378_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1091\/mbc.e06-09-0785","volume":"18","author":"Q Ren","year":"2007","unstructured":"Ren Q, Barber HK, Crawford GL, Karim ZA, Zhao C, Choi W, et al. Endobrevin\/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol Biol Cell. 2007;18(1):24\u201333.","journal-title":"Mol Biol Cell"},{"issue":"4","key":"4378_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4048\/jbc.2018.21.e57","volume":"21","author":"M Yuan","year":"2018","unstructured":"Yuan M, Liao J, Luo J, Cui M, Jin F. Significance of Vesicle-Associated Membrane Protein 8 Expression in Predicting Survival in Breast Cancer. J Breast Cancer. 2018;21(4):399\u2013405.","journal-title":"J Breast Cancer"},{"key":"4378_CR29","doi-asserted-by":"publisher","unstructured":"Vitto VAM, Bianchin S, Zolondick AA, Pellielo G, Rimessi A, Chianese D, et al. Molecular mechanisms of autophagy in cancer development, progression, and therapy. Biomedicines. 2022;10(7). https:\/\/doi.org\/10.3390\/biomedicines10071596.","DOI":"10.3390\/biomedicines10071596"},{"key":"4378_CR30","doi-asserted-by":"publisher","first-page":"5478574","DOI":"10.1155\/2020\/5478574","volume":"2020","author":"H Ding","year":"2020","unstructured":"Ding H, Xiong XX, Fan GL, Yi YX, Chen YR, Wang JT, et al. The new biomarker for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) based on public database mining. BioMed Res Int. 2020;2020:5478574.","journal-title":"BioMed Res Int"},{"key":"4378_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods in molecular biology (Clifton, NJ). 2018;1711:243\u201359.","journal-title":"Methods in molecular biology (Clifton, NJ)"},{"issue":"23","key":"4378_CR32","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1002\/cam4.4341","volume":"10","author":"Y Jin","year":"2021","unstructured":"Jin Y, Wang Z, He D, Zhu Y, Chen X, Cao K. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer Med. 2021;10(23):8693\u2013707.","journal-title":"Cancer Med"},{"issue":"3","key":"4378_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.devcel.2004.08.002","volume":"7","author":"CC Wang","year":"2004","unstructured":"Wang CC, Ng CP, Lu L, Atlashkin V, Zhang W, Seet LF, et al. A role of VAMP8\/endobrevin in regulated exocytosis of pancreatic acinar cells. Dev Cell. 2004;7(3):359\u201371.","journal-title":"Dev Cell"},{"issue":"7","key":"4378_CR34","first-page":"2535","volume":"118","author":"LI Cosen-Binker","year":"2008","unstructured":"Cosen-Binker LI, Binker MG, Wang CC, Hong W, Gaisano HY. VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. J Clin Invest. 2008;118(7):2535\u201351.","journal-title":"J Clin Invest"},{"issue":"1","key":"4378_CR35","doi-asserted-by":"publisher","first-page":"2230641","DOI":"10.1080\/15384047.2023.2230641","volume":"24","author":"S Yang","year":"2023","unstructured":"Yang S, Zhou P, Zhang L, Xie X, Zhang Y, Bo K, et al. VAMP8 suppresses the metastasis via DDX5\/\u03b2-catenin signal pathway in osteosarcoma. Cancer Biol Ther. 2023;24(1):2230641.","journal-title":"Cancer Biol Ther"},{"key":"4378_CR36","doi-asserted-by":"publisher","unstructured":"Ghosh R, Samanta P, Sarkar R, Biswas S, Saha P, Hajra S, et al. Targeting HIF-1\u03b1 by natural and synthetic compounds: a promising approach for anti-cancer therapeutics development. Molecules. 2022;27(16). https:\/\/doi.org\/10.3390\/molecules27165192.","DOI":"10.3390\/molecules27165192"},{"issue":"9","key":"4378_CR37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1101\/gad.1529107","volume":"21","author":"JJ Lum","year":"2007","unstructured":"Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 2007;21(9):1037\u201349.","journal-title":"Genes Dev"},{"key":"4378_CR38","doi-asserted-by":"publisher","first-page":"8457","DOI":"10.2147\/CMAR.S328058","volume":"13","author":"MP Lux","year":"2021","unstructured":"Lux MP, Ciani O, Dunlop WCN, Ferris A, Friedlander M. The impasse on overall survival in oncology reimbursement decision-making: how can we resolve this? Cancer Manag Res. 2021;13:8457\u201371.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"4378_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","volume":"11","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xing C, Deng Y, Ye C, Peng H. HIF-1\u03b1 signaling: essential roles in tumorigenesis and implications in targeted therapies. Genes Dis. 2024;11(1):234\u201351.","journal-title":"Genes Dis"},{"issue":"3","key":"4378_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s12276-024-01180-8","volume":"56","author":"T Bae","year":"2024","unstructured":"Bae T, Hallis SP, Kwak MK. Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer. Exp Mol Med. 2024;56(3):501\u201314.","journal-title":"Exp Mol Med"},{"issue":"1","key":"4378_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther. 2021;6(1):72.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4378_CR42","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC, Mu J, et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 2023;12(10):11149\u201365.","journal-title":"Cancer Med"},{"key":"4378_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342.","journal-title":"Cancer Lett"},{"issue":"4","key":"4378_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15252\/emmm.201404271","volume":"7","author":"A McIntyre","year":"2015","unstructured":"McIntyre A, Harris AL. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality. EMBO Mol Med. 2015;7(4):368\u201379.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4378_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"key":"4378_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.950079","volume":"13","author":"M Ghasemi","year":"2022","unstructured":"Ghasemi M, Abbasi L, Ghanbari Naeini L, Kokabian P, Nameh Goshay Fard N, Givtaj N. Dendritic cells and natural killer cells: the road to a successful oncolytic virotherapy. Front Immunol. 2022;13:950079.","journal-title":"Front Immunol"},{"key":"4378_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.621254","volume":"11","author":"EE Peterson","year":"2020","unstructured":"Peterson EE, Barry KC. The natural killer-dendritic cell immune axis in anti-cancer immunity and immunotherapy. Front Immunol. 2020;11:621254.","journal-title":"Front Immunol"},{"issue":"5","key":"4378_CR48","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.7150\/jca.65074","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Ren H, Fu J. Combinations of radiotherapy with immunotherapy in cervical cancer. J Cancer. 2022;13(5):1480\u20139.","journal-title":"J Cancer"},{"issue":"3","key":"4378_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/ijgc-2021-002492","volume":"32","author":"MV Sherer","year":"2022","unstructured":"Sherer MV, Kotha NV, Williamson C, Mayadev J. Advances in immunotherapy for cervical cancer: recent developments and future directions. Int J Gynecol Cancer. 2022;32(3):281\u20137.","journal-title":"Int J Gynecol Cancer"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04378-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04378-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04378-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:06:01Z","timestamp":1759921561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04378-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04378-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in full accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Obstetrics and Gynecology Hospital of Fudan University for the use of human clinical specimens (Approval No. 2019\u201353). All participants provided written informed consent prior to their inclusion in the study. All animal experiments were performed in compliance with institutional guidelines and were reviewed and approved by the Animal Care and Use Committee of the Obstetrics and Gynecology Hospital of Fudan University. The study is reported in accordance with the ARRIVE guidelines for animal experiments and the TRIPOD statement for the prognostic prediction study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"544"}}